Power Law company profile

DICE Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2013 · IPO 2021 Unicorn

Developing transformative medicines for autoimmune and inflammatory diseases

Valuation

$2.40B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

15 investors on DICE Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 15 investors entered at this stage

Soleus Capital

Eventide Asset Management

Logos Capital

RA Capital Management

Alexandria Equities

New Leaf Venture Partners

Agent Capital

Driehaus Capital Management

Northpond Ventures

Janus Henderson Investors

Sands Capital Management

Sanofi Ventures

Asymmetry capital management

Altitude Life Science Ventures

Osage University Partners

Global footprint

Where DICE Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · South San Francisco HQ

Book a demo for the full country breakdown

Web traffic by country

560 monthly visits
across markets

🇺🇸 United States107.1%

Top 1 markets shown

Patent intelligence

$6M patent portfolio · 20 active families

Estimated portfolio value

$6M

0.27% of market cap · 35.6× smaller than top peer Galapagos ($230M)

20 active patent families

Where DICE Therapeutics innovates Pharmaceutical drugMolecular biologyUlcerative colitisIntegrinSmall molecule

Where DICE Therapeutics concentrates vs peers

Each axis is a top-10 topic across DICE Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about DICE Therapeutics

An AI-synthesized read of the highest-engagement posts about DICE Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DICE Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles